Meta-methodology: conducting and reporting meta-analyses.
作者信息
Turner J Rick, Durham Todd A
出版信息
J Clin Hypertens (Greenwich). 2014 Feb;16(2):91-3. doi: 10.1111/jch.12215.
Abstract
摘要
相似文献
1
Meta-methodology: conducting and reporting meta-analyses.元方法学：进行和报告元分析
J Clin Hypertens (Greenwich). 2014 Feb;16(2):91-3. doi: 10.1111/jch.12215.
2
Resistant hypertension: multivariate predictors of blood pressure response to renal denervation.顽固性高血压：肾脏去神经支配后血压反应的多变量预测因素
Int J Cardiol. 2013 Oct 3;168(3):3130-2. doi: 10.1016/j.ijcard.2013.04.035. Epub 2013 May 6.
3
Pseudopheochromocytoma as a cause of resistant and paroxysmal hypertension successfully treated by percutaneous renal denervation.假性嗜铬细胞瘤作为经皮肾去神经术成功治疗的顽固性和阵发性高血压的病因
Rev Esp Cardiol (Engl Ed). 2013 Mar;66(3):227-9. doi: 10.1016/j.rec.2012.07.018. Epub 2012 Nov 10.
4
Witnessed drug intake before planned denervation--always harmless?在计划进行去神经支配之前目睹药物摄入——总是无害的吗？
Int J Cardiol. 2015 Jan 20;179:125-6. doi: 10.1016/j.ijcard.2014.10.162. Epub 2014 Oct 28.
5
Renal sympathetic denervation for resistant , hypertension--a novel treatment strategy.肾交感神经去支配术治疗顽固性高血压——一种新的治疗策略。
J Assoc Physicians India. 2013 Nov;61(11):834-6.
6
Aldosterone antagonists and renal denervation: friends or foes?醛固酮拮抗剂与肾去神经支配：是友还是敌？
Hypertension. 2015 Feb;65(2):280-2. doi: 10.1161/HYPERTENSIONAHA.114.04119. Epub 2014 Nov 24.
7
Comment on the Management of resistant hypertension in a multidisciplinary unit of renal denervation: protocol and results.肾去神经支配多学科单元中难治性高血压管理的评论：方案与结果
Rev Esp Cardiol (Engl Ed). 2013 Oct;66(10):830. doi: 10.1016/j.rec.2013.05.014. Epub 2013 Jul 24.
8
Catheter-based renal denervation for refractory hypertension: a review of the literature.基于导管的肾去神经术治疗顽固性高血压：文献综述
J Indian Med Assoc. 2012 May;110(5):292-6.
9
Comment on the Management of resistant hypertension in a multidisciplinary unit of renal denervation: protocol and results. Response.关于肾脏去神经支配多学科单元中难治性高血压管理的评论：方案与结果。回应。
Rev Esp Cardiol (Engl Ed). 2013 Oct;66(10):830-1. doi: 10.1016/j.rec.2013.06.003. Epub 2013 Aug 6.
10
Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.肾去神经术治疗高血压：重新出发，确保正确实施。
Clin Cardiol. 2015 Aug;38(8):447-54. doi: 10.1002/clc.22424. Epub 2015 Jul 27.
引用本文的文献
1
Real-World Effectiveness of Triple Extrafine Fixed-Dose Combination with Beclomethasone/Formoterol/Glycopyrronium on Symptoms and Lung Function in COPD: A Systematic Review and Meta-Analysis.布地奈德/福莫特罗/格隆溴铵三联超细微固定剂量组合对慢性阻塞性肺疾病症状和肺功能的真实世界有效性：一项系统评价和荟萃分析
Int J Chron Obstruct Pulmon Dis. 2025 May 27;20:1723-1736. doi: 10.2147/COPD.S511334. eCollection 2025.
2
Strength of association between comorbidities and asthma: a meta-analysis.共病与哮喘之间关联强度的荟萃分析。
Eur Respir Rev. 2023 Mar 8;32(167). doi: 10.1183/16000617.0202-2022. Print 2023 Mar 31.
3
Impact of Sex on Proper Use of Inhaler Devices in Asthma and COPD: A Systematic Review and Meta-Analysis.性别对哮喘和慢性阻塞性肺疾病患者吸入装置正确使用的影响：一项系统评价和荟萃分析
Pharmaceutics. 2022 Jul 28;14(8):1565. doi: 10.3390/pharmaceutics14081565.
4
Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis.基于干细胞的再生疗法和 COPD 衍生产品：系统评价和荟萃分析。
Cells. 2022 May 30;11(11):1797. doi: 10.3390/cells11111797.
5
Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics.年龄不影响抗IL-5/IL-5R治疗重症哮喘患者的疗效。
World Allergy Organ J. 2019 Nov 6;12(11):100081. doi: 10.1016/j.waojou.2019.100081. eCollection 2019 Nov.
6
The impact of dual bronchodilation on cardiovascular serious adverse events and mortality in COPD: a quantitative synthesis.双支气管扩张剂对 COPD 患者心血管严重不良事件和死亡率的影响：定量综合分析。
Int J Chron Obstruct Pulmon Dis. 2017 Dec 5;12:3469-3485. doi: 10.2147/COPD.S146338. eCollection 2017.
7
LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment.慢性阻塞性肺疾病中长效β2受体激动剂/长效抗胆碱能药物联合治疗：关于治疗持续时间的荟萃分析
Eur Respir Rev. 2017 Jan 17;26(143). doi: 10.1183/16000617.0043-2016. Print 2017 Jan.
8
Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis.N-乙酰半胱氨酸对慢性支气管炎或慢性阻塞性肺疾病急性加重的影响：一项荟萃分析。
Eur Respir Rev. 2015 Sep;24(137):451-61. doi: 10.1183/16000617.00002215.
本文引用的文献
1
Diagnosis and treatment of resistant hypertension: the critical role of ambulatory blood pressure monitoring.顽固性高血压的诊断与治疗：动态血压监测的关键作用
J Clin Hypertens (Greenwich). 2013 Dec;15(12):868-73. doi: 10.1111/jch.12200. Epub 2013 Sep 19.
2
Blood pressure changes after renal denervation at 10 European expert centers.欧洲10个专家中心肾去神经支配术后的血压变化
J Hum Hypertens. 2014 Mar;28(3):150-6. doi: 10.1038/jhh.2013.88. Epub 2013 Sep 26.
3
Review of the state of renal nerve ablation for patients with severe and resistant hypertension.重度顽固性高血压患者肾神经消融治疗现状综述
J Am Soc Hypertens. 2013 Nov-Dec;7(6):484-93. doi: 10.1016/j.jash.2013.07.003. Epub 2013 Aug 15.
4
Clinical trials in new drug development.新药研发中的临床试验。
J Clin Hypertens (Greenwich). 2013 May;15(5):306-9. doi: 10.1111/jch.12085. Epub 2013 Mar 13.
5
Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol).卡维地洛与β1 选择性β受体阻滞剂（阿替洛尔、比索洛尔、美托洛尔和奈必洛尔）的荟萃分析。
Am J Cardiol. 2013 Mar 1;111(5):765-9. doi: 10.1016/j.amjcard.2012.11.031. Epub 2013 Jan 4.
6
Renal sympathetic denervation for treatment of resistant hypertension: a systematic review.肾去交感神经术治疗耐药性高血压：系统评价。
J Clin Hypertens (Greenwich). 2013 Jan;15(1):75-84. doi: 10.1111/jch.12027. Epub 2012 Oct 26.
7
The 50th anniversary of the Kefauver-Harris Amendments: efficacy assessment and the randomized clinical trial.《凯弗维尔-哈里斯修正案》五十周年：疗效评估与随机临床试验
J Clin Hypertens (Greenwich). 2012 Nov;14(11):810-5. doi: 10.1111/jch.12012. Epub 2012 Oct 3.
8
Should ambulatory blood pressure monitoring be mandatory for future studies in resistant hypertension: a perspective.是否应该将动态血压监测作为难治性高血压未来研究的强制性要求：一种观点。
J Hypertens. 2012 May;30(5):874-6. doi: 10.1097/HJH.0b013e328352c3c7.
9
The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.交感神经系统和治疗高血压的新非药物方法：以肾脏去神经支配为重点。
Can J Cardiol. 2012 May;28(3):311-7. doi: 10.1016/j.cjca.2011.11.005. Epub 2012 Jan 14.
Zotero 插件